Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Journal of Physics. Condensed Matter : an Institute of Physics Journal|January 20, 2018
Exploring the role of genome and structural ions in preventing viral capsid collapse during dehydrationNatalia Martín-González, Sofía M Guérin Darvas, Aritz Durana, et al.
The Journal of General Virology|January 5, 2013
Cryo-electron microscopy reconstructions of triatoma virus particles: a clue to unravel genome delivery and capsid disassemblyJ Agirre, G Goret, M LeGoff, et al.
Structure (London, England : 1993)|February 9, 2011
Structural insights into the oligomerization and architecture of eukaryotic membrane pore-forming toxinsAriel E Mechaly, Augusto Bellomio, David Gil-Cartón, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 22, 2010
Economic burden of comorbidities in patients with psoriasis is substantialA B Kimball, A Guérin, M Tsaneva, et al.
Virology|March 1, 2008
Phasing of the Triatoma virus diffraction data using a cryo-electron microscopy reconstructionL F Estrozi, E Neumann, G Squires, et al.
Acta Crystallographica. Section D, Biological Crystallography|August 31, 2004
Purification, crystallization and preliminary X-ray analysis of Triatoma virus (TrV) from Triatoma infestansGabriela S Rozas-Dennis, Gaëlle Squires, Joan Pous, et al.
Cancer|September 1, 1995
Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patients. GETCB (Groupe d'Etude et de Traitement des Cancers Bronchiques)B Dautzenberg, C Chastang, R Arriagada, et al.
Journal of Structural Biology|June 26, 2012
Pores of the toxin FraC assemble into 2D hexagonal clusters in both crystal structures and model membranesAriel E Mechaly, Augusto Bellomio, Koldo Morante, et al.
The British Journal of Dermatology|August 18, 2012
Sleep quality and other patient-reported outcomes improve after patients with psoriasis with suboptimal response to other systemic therapies are switched to adalimumab: results from PROGRESS, an open-label Phase IIIB trialB E Strober, J M Sobell, K C Duffin, et al.
Biochimica Et Biophysica Acta|March 13, 2010
Interdomain Ca(2+) effects in Escherichia coli alpha-haemolysin: Ca(2+) binding to the C-terminal domain stabilizes both C- and N-terminal domainsLissete Sánchez-Magraner, Aitziber L Cortajarena, Marcos García-Pacios, et al.
Pageof 9